Dueling Medication Abortion Court Rulings Lead to Tighter Restrictions

On Apr. 7, 2023, two federal district court judges issued conflicting preliminary injunctions. On Apr. 12, 2023, 5th U.S. Circuit Court of Appeals issued a ruling on the Texas case allowing mifepristone to remain on the market while the case is heard, but restricting access: the drug may only be dispensed up to seven weeks of pregnancy instead of 10 and may not be dispensed through the mail.